Back to BERG Thomas

Thomas BERG

Germany

City: Leipzig

Institution: University Hospital Leipzig

Contact: leber@uniklinik-leipzig.de


Biography of Thomas BERG

Professor Dr. Thomas Berg completed his medical training at the Universities of Tübingen, Freiburg and Berlin, Germany. He specialized in internal medicine in 2001 and in Gastroenterology and Hepatology in 2007 at the University Medicine Berlin, and became a lecturer in this subject in 2002.
In 2002, Professor Berg took up the position of Associate Director and Professor of Medicine at the Department of Hepatology and Gastroenterology of Charité, Campus Virchow-Clinic, University Medicine in Berlin, where he was Head of the Liver Out-Patient Clinic and the Laboratory for Molecular Hepatitis and Viral Diagnostics.
Since December 2009, he has been the Head of the Section of Hepatology at the University Hospital in Leipzig, Germany, and since October 2018 acting Director of the Clinic of Gastroenterology at the University Hospital, Leipzig.
His clinical and translational research is focused on chronic viral hepatitis, liver transplantation, hepatocellular carcinoma, genetics in liver disease, and liver failure, and he participated in numerous national and international clinical trials.
He is Vice Secretary of the European Associations for the Study of the Liver (EASL), Board member of the EASL International Liver Foundation (EILF) and Co-Editor of the Journal of Hepatology since 2014.
He is also member of the American (AASLD), European (EASL), and German (GASL) Associations for the Study of the Liver, The European Society for Organ Transplantation (ESOT), The European Liver and Intestine Transplant Association (ELITA), German Transplantation Society (DTG), Working Group Internal Oncology (AiO), Working Group Gastroenterological Oncology (AGO), German Cancer Society (DKG), German Society of Gastroenterology (DGVS), and the representative of the DGVS in the foundation council of the German liver foundation. He has published more than 350 articles in peer-reviewed journals and more than 100 reviews and textbook contributions. His h-index is 72 (Scopus).

PHC's participations

Monday, March 27th 2023

International treatment guidelines -

Monday, March 08th 2021

The COVID-19, NASH and other liver diseases: lessons learned

MEETING WITH THE 2020 NOBEL LAUREATES (chairman)

13th PHC – 2020

Monday, January 13th 2020

New endpoints and biomarkers for treatment of CHB -

LUNCH WORKSHOPS - 1. Hepatitis B : practical management: Room 251 (chairman)

12th PHC – 2019

Monday, January 14th 2019

LUNCH WORKSHOPS - 2-Treatment of hepatitis B: the guidelines and real life: Room 252B (chairman)

4th PHC – 2011

Tuesday, January 18th 2011

Interactive luncheons: regional management issues - Room 4 (chairman)

6th PHC – 2013

Tuesday, January 15th 2013

Interactive Luncheons - Room 3

Cirrhosis -

7th PHC – 2014

Tuesday, January 14th 2014

Interactive luncheons - Room 4 -

11th PHC – 2018

Monday, January 15th 2018

- Speakers: (chairman) -

Tuesday, January 16th 2018

YES

Luncheon Workshops - (chairman)

8th PHC – 2015

Monday, January 12th 2015

Shortened therapy with IFN-based therapy -